Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Roche's MabThera and Xeloda cleared for new indications in Europe

March 26, 2002

Amsalog well tolerated at oral doses up to 1600 mg/m2 in cancer patients

March 26, 2002

Recent patent covers Agouron's CDK inhibitors

March 25, 2002

Novel GnRH antagonists for sex hormone-dependent conditions identified at GSK

March 22, 2002

Cell Genesys discontinues p27/p16 gene therapy collaboration

March 22, 2002

TAS-108, a safer antiestrogen for breast cancer

March 22, 2002

Irofulven tested in cancer patients in combination with cisplatin

March 21, 2002

Aventis discloses compounds active against telomerase

March 21, 2002

Compounds for cancer gene therapy reported by Fujisawa

March 21, 2002

Rationally designed anticancer drugs targeting key enzymes as a new approach to breast cancer

March 21, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 1, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...